SATAVAPTAN

UNII:	AJS8S3P31H
Formula:	C₃₃H₄₅N₃O₈S
Preferred Substance Name:	SATAVAPTAN
InChIKey:	QKXJWFOKVQWEDZ-VCCCEUOBSA-N

185913-78-4
AQUILDA
BENZAMIDE, N-(1,1-DIMETHYLETHYL)-4-((5'-ETHOXY-4-(2-(4-MORPHOLINYL)ETHOXY)-2'-OXOSPIRO(CYCLOHEXANE-1,3'-(3H)INDOL)-1'(2'H)-YL)SULFONYL)-3-METHOXY-, CIS-
BENZAMIDE, N-(1,1-DIMETHYLETHYL)-4-((CIS-5'-ETHOXY-4-(2-(4-MORPHOLINYL)ETHOXY)-2'-OXOSPIRO(CYCLOHEXANE-1,3'-(3H)INDOL)-1'(2'H)-YL)SULFONYL)-3-METHOXY-
N-TERT-BUTYL-4-(((1S,4S)-5'-ETHOXY-4-(2-MORPHOLIN-4-YLETHOXY)-2'-OXOSPIRO(CYCLOHEXANE-1,3'-INDOL)-1'(2'H)-YL)SULFONYL)-3-METHOXYBENZAMIDE
SATAVAPTAN [INN]
SATAVAPTAN [MART.]
SATAVAPTAN [WHO-DD]
SR121463
SR-121463
SR-121463A

Note

UNIIs are generated based on scientific identity characteristics using ISO 11238 data elements. UNII availability does not imply any regulatory review or approval. Synonyms and mappings are based on the best public information available at the time of publication. Please report any problems/errors associated with this data to FDA-SRS@fda.hhs.gov.

SATAVAPTAN

Synonyms and Mappings

Resources